These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15977925)

  • 1. Human immunodeficiency virus and hypogonadal bone disease.
    Miller MG; Mulligan T
    Pharmacotherapy; 2005 Apr; 25(4):632-4; discussion 634. PubMed ID: 15977925
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of bone mass in male hypogonadal osteopenic subjects by androgens.
    Gupta SK; Ghotekar LH
    Natl Med J India; 1997; 10(6):285-7. PubMed ID: 9481102
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone health in hypogonadal men.
    Irwig MS
    Curr Opin Urol; 2014 Nov; 24(6):608-13. PubMed ID: 25144148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of osteoporosis in hypogonadal men].
    Marumo K; Hata K; Hagiuda J
    Clin Calcium; 2016 Jul; 26(7):1053-9. PubMed ID: 27346318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypogonadism and osteoporosis].
    Chaki O
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():426-34. PubMed ID: 11979939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Testosterone and bone: indications and limitations].
    Stoll D; Puder JJ; Lamy O
    Rev Med Suisse; 2011 Jun; 7(299):1311-5. PubMed ID: 21793421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
    Schubert M; Bullmann C; Minnemann T; Reiners C; Krone W; Jockenhövel F
    Horm Res; 2003; 60(1):21-8. PubMed ID: 12792150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alendronate for osteoporosis in men with androgen-repleted hypogonadism.
    Shimon I; Eshed V; Doolman R; Sela BA; Karasik A; Vered I
    Osteoporos Int; 2005 Dec; 16(12):1591-6. PubMed ID: 16362147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of osteoporosis in male hypogonadism].
    Tsukamoto T; Itoh N
    Clin Calcium; 2006 Mar; 16(3):481-5. PubMed ID: 16508132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone and Men's Health. Androgen replacement therapy and bone metabolism].
    Ogawa S
    Clin Calcium; 2010 Feb; 20(2):251-7. PubMed ID: 20118518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism.
    Zacharin MR; Pua J; Kanumakala S
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):691-5. PubMed ID: 12780744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).
    Shigehara K; Konaka H; Koh E; Nakashima K; Iijima M; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Sugimoto K; Iwamoto T; Mizokami A; Namiki M
    Aging Male; 2017 Sep; 20(3):139-145. PubMed ID: 28347184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches.
    Anapliotou ML; Kastanias IT; Psara P; Evangelou EA; Liparaki M; Dimitriou P
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):279-87. PubMed ID: 7758233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
    Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has prolactin a role in the hypogonadal status of HIV-infected patients?
    Collazos J; Esteban M
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):43-6. PubMed ID: 19171915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome in HIV-seropositive patients.
    Kell P
    Int J STD AIDS; 2007 Jul; 18(7):507-8. PubMed ID: 17623515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Osteoporosis and male hypogonadism].
    Medraś M; Jóźków P
    Pol Merkur Lekarski; 2000 Jul; 8(49):494-7. PubMed ID: 11070725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation.
    Francis RM; Peacock M; Aaron JE; Selby PL; Taylor GA; Thompson J; Marshall DH; Horsman A
    Bone; 1986; 7(4):261-8. PubMed ID: 3768204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.